1. Yingjie Xu, et al. Eur J Pharmacol. 2024 Apr 5:968:176422. PMID: 38365108
Suramin inhibits phenotypic transformation of vascular smooth muscle cells and neointima hyperplasia by suppressing transforming growth factor beta receptor 1 /Smad2/3 pathway activation
2. Xiaohui Wu ,et al. Pharmacol Res. 2022 Feb:176:106051 PMID: 34973467
LDHA mediated degradation of extracellular matrix is a potential target for the treatment of aortic dissection
3. Zicheng Wan, et al. RSC Adv. 2025 May 12;15(20):15639–15650. PMID: 40365194
Trials of a drug release platform in near-spherical porous NiTi alloys containing a thermosensitive hydrogel as the inner coating
|